Jonathan B. Siegel

CIK: 0001588209

Transaction Breakdown

Open Market Buys (P)2 (28.6%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)4 (57.1%)

Compensation grants

Other (G, F, J, C, D, …)1 (14.3%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

JAGX

Jaguar Health, Inc.

Director

Discretionary Trading P&L

Holdings

Transaction History (7 total)

JAGX
Jaguar Health, Inc.
Dec 11, 2025
Award(A)
Direct
7.4K shares-
JAGX
Jaguar Health, Inc.
Jun 24, 2025
Disposition(D)
Convertible Promissory Note
Indirect
9K shares at avg. $50000.00-
JAGX
Jaguar Health, Inc.
Jun 24, 2025
Award(A)
Convertible Promissory Note
Indirect
9.5K shares at avg. $50000.00-
JAGX
Jaguar Health, Inc.
Jun 24, 2025
Award(A)
Warrant to Purchase Common Stock
Indirect
18.3K shares-
JAGX
Jaguar Health, Inc.
Mar 31, 2025
Purchase(P)
Warrant to Purchase Common Stock
Indirect
9K shares-
JAGX
Jaguar Health, Inc.
Mar 31, 2025
Purchase(P)
Convertible Promissory Note
Indirect
9K shares at avg. $50000.00-
JAGX
Jaguar Health, Inc.
Oct 8, 2024
Award(A)
Stock option (right to buy)
Direct
26.5K shares-

		Type	Shares	Price		Ownership
Dec 11, 2025	JAGX Jaguar Health, Inc.	Award(A)	7,377	-	-	Direct
Jun 24, 2025	JAGX Jaguar Health, Inc.	Disposition(D) Convertible Promissory Note	9,000	$50000.00	-	Indirect
Jun 24, 2025	JAGX Jaguar Health, Inc.	Award(A) Convertible Promissory Note	9,462	$50000.00	-	Indirect
Jun 24, 2025	JAGX Jaguar Health, Inc.	Award(A) Warrant to Purchase Common Stock	18,262	-	-	Indirect
Mar 31, 2025	JAGX Jaguar Health, Inc.	Purchase(P) Warrant to Purchase Common Stock	9,000	-	-	Indirect
Mar 31, 2025	JAGX Jaguar Health, Inc.	Purchase(P) Convertible Promissory Note	9,000	$50000.00	-	Indirect
Oct 8, 2024	JAGX Jaguar Health, Inc.	Award(A) Stock option (right to buy)	26,500	-	-	Direct

1-7 of 7 transactions

About Siegel Jonathan B.

Siegel Jonathan B. (SEC CIK 0001588209) files insider reports with the SEC as Director of Jaguar Health, Inc. (JAGX).

Signal8 holds 4 ownership filings by Siegel Jonathan B., all Form 4s, filed between Oct 10, 2024 and Dec 15, 2025. Those filings report 7 transactions, from Oct 8, 2024 to Dec 11, 2025. Signal8's Form 4 history starts in Sep 2024.

The business address on Siegel Jonathan B.'s filings is in SAN FRANCISCO, CA.

Recent filings by Siegel Jonathan B.

Dec 11, 2025: Grant or award of JAGX shares (Form 4, code A).
Jun 24, 2025: Disposition to issuer transaction of JAGX derivative securities (Form 4, code D).
Jun 24, 2025: Grants or awards of JAGX derivative securities (2 lines, Form 4, code A).
Mar 31, 2025: Open-market purchases of JAGX derivative securities (2 lines, Form 4, code P).
Oct 8, 2024: Grant or award of JAGX derivative securities (Form 4, code A).

Other insiders filing for Jaguar Health, Inc. (JAGX)

MICEK JOHN, Director
King Steven R.
CONTE LISA A
Wolin Jonathan S.
Chaturvedi Pravin R, Chief Scientific Officer
BOCHNOWSKI JAMES J, Director

How to read Form 4 transaction codes